Next PMDA Consultation after Review of CardiAMP HF Trial DataSUNNYVALE, Calif., Dec. 04, 2024 (GLOBE NEWSWIRE) -- [Nasdaq: BCDA], a global leader in cellular and cell-derived therapeutics for the ...
Hepatic ischemia-reperfusion injury (HIRI) is a key factor leading to complications and poor prognosis after hepatobiliary surgery, but its pathogenesis remains unclear. Hence, it is a very necessary ...
Factors portending the greatest risk for cardiovascular death in control patients were inflammation (baseline plasma high-sensitivity C-reactive protein =2 mg/L; p=0.003) and ischemic HFrEF etiology ...
It has now been 25 years since prourokinase was in the spotlight as a potential treatment for acute ischaemic stroke. In 1999, the PROACT-II randomised controlled trial compared intra-arterial ...